{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:54:28Z","timestamp":1794455668620,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Program on Cancer Prevention and Control from the Gabonese Ministry of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67777-3","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T15:24:27Z","timestamp":1766589867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vaccine-preventable HPV burden and cervical abnormalities in women during 2022\u20132024 Octobre Rose campaigns in Libreville"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1653-9935","authenticated-orcid":false,"given":"Alfred K. F.","family":"Mabika-Obanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Ambounda Ledaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystina","family":"Ngou Milama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5000-4520","authenticated-orcid":false,"given":"V\u00e9nusia","family":"Zang Obame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel Kevin","family":"Alame-Emane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adama","family":"Sanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corneille","family":"Ndong-Ella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9251-2908","authenticated-orcid":false,"given":"Hugues","family":"Loemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"B\u00e9lec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Ngou Mve Ngou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulin N.","family":"Essone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armel","family":"Mintsa-Ndong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph-Sydney","family":"Mboumba Bouassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-0153","authenticated-orcid":false,"given":"Jo\u00ebl Fleury","family":"Djoba Siawaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"67777_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/14787210.2017.1322902","volume":"15","author":"RS Mboumba Bouassa","year":"2017","unstructured":"Mboumba Bouassa, R. S. et al. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease. Expert Rev. Anti Infect. Ther. 15, 613\u2013627 (2017).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"67777_CR2","unstructured":"Ferlay J. et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.who.int\/today (2024)."},{"key":"67777_CR3","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni, L. et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J. Infect. Dis. 202, 1789\u20131799 (2010).","journal-title":"J. Infect. Dis."},{"key":"67777_CR4","unstructured":"International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Cancer-Preventive Interventions. IARC Handbooks of Cancer Prevention, Volume 18: Cervical Cancer Screening. Lyon (FR): International Agency for Research on Cancer; 2022. ISBN: 978-92-832-3025-0 (print) \/ 978-92-832-3024-3 (e-book): https:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Iarc-Handbooks-Of-Cancer-Prevention\/Cervical-Cancer-Screening-2022 (2022)."},{"key":"67777_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","volume":"404","author":"F Wei","year":"2024","unstructured":"Wei, F., Georges, D., Man, I., Baussano, I. & Clifford, G. M. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet 404, 435\u2013444 (2024).","journal-title":"Lancet"},{"key":"67777_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/jmv.20472","volume":"77","author":"A Si-Mohamed","year":"2005","unstructured":"Si-Mohamed, A. et al. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon. J. Med. Virol. 77, 430\u2013438 (2005).","journal-title":"J. Med. Virol."},{"key":"67777_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/OLQ.0b013e3181fc6ec0","volume":"38","author":"G Sangwa-Lugoma","year":"2011","unstructured":"Sangwa-Lugoma, G. et al. Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community. Sex. Transm. Dis. 38, 308\u2013315 (2011).","journal-title":"Sex. Transm. Dis."},{"key":"67777_CR8","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/ijc.28834","volume":"135","author":"S Untiet","year":"2014","unstructured":"Untiet, S. et al. HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy. Int. J. Cancer 135, 1911\u20131917 (2014).","journal-title":"Int. J. Cancer"},{"key":"67777_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canep.2015.11.008","volume":"40","author":"R Catarino","year":"2016","unstructured":"Catarino, R. et al. Risk factors associated with human papillomavirus prevalence and cervical neoplasia among Cameroonian women. Cancer Epidemiol. 40, 60\u201366 (2016).","journal-title":"Cancer Epidemiol."},{"key":"67777_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13027-016-0098-1","volume":"11","author":"PB Moussavou","year":"2016","unstructured":"Moussavou, P. B. et al. Molecular analysis of human Papillomavirus detected among women positive for cervical lesions by visual inspection with acetic acid\/Lugol\u2019s iodine (VIA\/VILI) in Libreville, Gabon. Infect. Agent Cancer 11, 50 (2016).","journal-title":"Infect. Agent Cancer"},{"key":"67777_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-016-0091-8","volume":"11","author":"S Zoa-Assoumou","year":"2016","unstructured":"Zoa-Assoumou, S. et al. Human papillomavirus genotypes distribution in cervical cancer cases in Gabon. Infect. Agent Cancer 11, 42 (2016).","journal-title":"Infect. Agent Cancer"},{"key":"67777_CR12","doi-asserted-by":"crossref","unstructured":"Zoa Assoumou S. et al. Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities. Infect Agent Cancer. 11, 2 (2016).","DOI":"10.1186\/s13027-016-0046-0"},{"key":"67777_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12985-017-0906-2","volume":"14","author":"P Moussavou-Boundzanga","year":"2017","unstructured":"Moussavou-Boundzanga, P. et al. Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population. Virol. J. 14, 241 (2017).","journal-title":"Virol. J."},{"key":"67777_CR14","doi-asserted-by":"publisher","first-page":"e0217486","DOI":"10.1371\/journal.pone.0217486","volume":"14","author":"RS Mboumba Bouassa","year":"2019","unstructured":"Mboumba Bouassa, R. S. et al. High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N\u2019Djamena, Chad. PLoS One 14, e0217486 (2019).","journal-title":"PLoS One"},{"key":"67777_CR15","doi-asserted-by":"publisher","first-page":"890880","DOI":"10.3389\/fpubh.2022.890880","volume":"10","author":"A Seyoum","year":"2022","unstructured":"Seyoum, A. et al. Prevalence and genotype distribution of high-risk human Papillomavirus infection among Sub-Saharan African Women: a systematic review and meta-analysis. Front, Public Health 10, 890880 (2022).","journal-title":"Front, Public Health"},{"key":"67777_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-023-00493-z","volume":"18","author":"P Moussavou-Boundzanga","year":"2023","unstructured":"Moussavou-Boundzanga, P. et al. HPV genotypes in high-grade cervical lesions and invasive cervical carcinoma detected in Gabonese women. Infect. Agent Cancer 18, 16 (2023).","journal-title":"Infect. Agent Cancer"},{"key":"67777_CR17","doi-asserted-by":"publisher","first-page":"104762","DOI":"10.1016\/j.idnow.2023.104762","volume":"53","author":"Tsimba","year":"2023","unstructured":"Tsimba et al. Human papillomavirus genotype distribution by cytological status and associated risk factors in the general population of Congolese women living in urban and rural areas: Implications for cervical cancer prevention. Infect. Dis. Now. 53, 104762 (2023).","journal-title":"Infect. Dis. Now."},{"key":"67777_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/s12905-024-03403-6","volume":"24","author":"C Mombo-Maganga","year":"2024","unstructured":"Mombo-Maganga, C. et al. Prevalence of high-risk human papillomavirus genotypes and viral load correlated with squamous cell inflammation among women in Gabon. BMC Women\u2019s. Health 24, 561 (2024).","journal-title":"BMC Women\u2019s. Health"},{"key":"67777_CR19","unstructured":"Ministry of Economy and Finance of the Republic of Gabon. [Gabonese population projection 2019-2025]: https:\/\/statgabon.ga\/wp-content\/uploads\/2020\/08\/Rapport_Proj_Dem_Gabon_V2.pdf (2020)."},{"key":"67777_CR20","unstructured":"Bruni, L. et al. de Sanjos\u00e9 S. ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Gabon. Summary Report 10 March 2023: https:\/\/hpvcentre.net\/statistics\/reports\/GAB.pdf (2023)."},{"key":"67777_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/vaccines13030301","volume":"13","author":"F Mboussou","year":"2025","unstructured":"Mboussou, F. et al. The 2024 Annual Meeting of the essential programmes on immunization managers in Central Africa: a peer learning platform. Vaccines 13, 301 (2025).","journal-title":"Vaccines"},{"key":"67777_CR22","unstructured":"World Health Organization (WHO). Human papillomavirus vaccines: WHO position paper, December 2022. 97th YEAR. No 50, 2022, 97, 645\u2013672: https:\/\/iris.who.int\/bitstream\/handle\/10665\/365350\/WER9750-eng-fre.pdf?sequence=1 (2022)."},{"key":"67777_CR23","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/ijc.31281","volume":"142","author":"P Gray","year":"2018","unstructured":"Gray, P. et al. Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II). Int. J. Cancer 142, 2491\u20132500 (2018).","journal-title":"Int. J. Cancer"},{"key":"67777_CR24","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1080\/21645515.2018.1564438","volume":"15","author":"C Covert","year":"2019","unstructured":"Covert, C. et al. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. Hum. Vaccin Immunother. 15, 1962\u20131969 (2019).","journal-title":"Hum. Vaccin Immunother."},{"key":"67777_CR25","doi-asserted-by":"publisher","first-page":"e0264498","DOI":"10.1371\/journal.pone.0264498","volume":"17","author":"ZZA Mbulawa","year":"2022","unstructured":"Mbulawa, Z. Z. A., Phohlo, K., Garcia-Jardon, M., Williamson, A. L. & Businge, C. B. High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention. PLoS One 17, e0264498 (2022).","journal-title":"PLoS One"},{"key":"67777_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93485-1","volume":"11","author":"RP Mendoza","year":"2021","unstructured":"Mendoza, R. P. et al. Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer. Sci. Rep. 11, 14064 (2021).","journal-title":"Sci. Rep."},{"key":"67777_CR27","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/ijc.33033","volume":"147","author":"M Pinheiro","year":"2020","unstructured":"Pinheiro, M. et al. Association of HPV35 with cervical carcinogenesis among women of African ancestry: evidence of viral-host interaction with implications for disease intervention. Int. J. Cancer 147, 2677\u20132686 (2020).","journal-title":"Int. J. Cancer"},{"key":"67777_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297054","volume":"19","author":"RS Mboumba Bouassa","year":"2024","unstructured":"Mboumba Bouassa, R. S. et al. Genetic diversity of HPV35 in Chad and the Central African Republic, two landlocked countries of Central Africa: a cross-sectional study. PLoS One 19, e0297054 (2024).","journal-title":"PLoS One"},{"key":"67777_CR29","doi-asserted-by":"publisher","first-page":"1362770","DOI":"10.3389\/fimmu.2024.1362770","volume":"15","author":"R Wang","year":"2024","unstructured":"Wang, R. et al. Current status and future directions for the development of human papillomavirus vaccines. Front. Immunol. 15, 1362770 (2024).","journal-title":"Front. Immunol."},{"key":"67777_CR30","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1128\/JVI.03534-13","volume":"88","author":"AA Chen","year":"2014","unstructured":"Chen, A. A. et al. IARC HPV Variant Study Group. Human papillomavirus 45 genetic variation and cervical cancer risk worldwide. J. Virol. 88, 4514\u20134521 (2014).","journal-title":"J. Virol."},{"key":"67777_CR31","doi-asserted-by":"publisher","first-page":"100202","DOI":"10.1016\/j.pvr.2020.100202","volume":"10","author":"DG Ferris","year":"2020","unstructured":"Ferris, D. G. et al. Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial. Papillomavirus Res. 10, 100202 (2020).","journal-title":"Papillomavirus Res."},{"key":"67777_CR32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/diseases13080260","volume":"13","author":"M Mboumba-Mboumba","year":"2025","unstructured":"Mboumba-Mboumba, M. et al. The high prevalence of oncogenic HPV genotypes targeted by the nonavalent HPV vaccine in HIV-infected women urgently reinforces the need for prophylactic vaccination in key female populations living in Gabon. Diseases 13, 260 (2025).","journal-title":"Diseases"},{"key":"67777_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/tropicalmed10060157","volume":"10","author":"J Muwonga Tukisadila","year":"2025","unstructured":"Muwonga Tukisadila, J. et al. Syndemic synergy of HPV, HIV, and HSV-2 for oncogenic HPV replication in female sex workers. Trop. Med. Infect. Dis. 10, 157 (2025).","journal-title":"Trop. Med. Infect. Dis."},{"key":"67777_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/ijc.29353","volume":"137","author":"J Bigoni","year":"2015","unstructured":"Bigoni, J. et al. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women. Int J. Cancer 137, 127\u2013134 (2015).","journal-title":"Int J. Cancer"},{"key":"67777_CR35","unstructured":"World health organization (WHO). Guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention [Internet]. 2nd edition. Geneva: Table 1, Screening and treatment recommendations and good practice statements for the general population of women and women living with HIV: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572314\/table\/fm-ch2.tab1\/ (2021)."},{"key":"67777_CR36","unstructured":"World health organization (WHO). Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: https:\/\/www.who.int\/publications\/i\/item\/9789240014107 (2020)."},{"key":"67777_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1874-9","volume":"15","author":"Z Sun","year":"2015","unstructured":"Sun, Z. et al. Development of a fluorescence-based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads. BMC Cancer 15, 860 (2015).","journal-title":"BMC Cancer"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67777-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:52:18Z","timestamp":1769521938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67777-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67777"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67777-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All women were aged 18 years and older and signed the written informed consent form of the study prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"1032"}}